Abstract
Toxoplasma gondii is an obligate intracellular parasite that infects all nucleate cells of vertebrates. Human infected by vertical transmission and also using raw or undercooked meat or food and water that contaminated with mature oocysts. Parkinson‘s disease as neurodegenerative disease affects people above 60 years. Due to high prevalence of toxoplasmosis in Iran and evidence about effects of T. gondii on neurodegenerative diseases, this study has been conducted to investigate possible correlation between Toxoplasma and Parkinson’s disease in Iran. Seventy five Parkinson’s patients and equal healthy volunteers were enrolled. After obtaining informed consent and sociodemographic features, 5 ml blood sample were collected and then anti-Toxoplasma IgG and IgM levels were examined by ELISA method. Data was analyzed with Chi-squre and Fisher’s test by usig stata 11 software. Binary logistic regression was used for multivariate analysis in assessing the correlation between toxoplasmosis and Parkinson. Eighty five percent of Parkinson’s group and 90.3 % of control group were positive for anti-Toxoplasma IgG antibody. In this investigation no statically differences were observed between groups and age, gender, residency and using raw or undercooked meat. There is no significant association between IgG positive titer and Parkinson’s disease. However, statistically significant association was found between Parkinson and keeping cat (P = 0.03) as well as the using of undercooked egg (P = 0.004). Although there is high level of anti-Toxoplasma IgG antibody in Parkinson’s patients which reflects chronic Toxoplasma infection; we couldn’t detect any statistical association between T. gondii infection and Parkinson’s disease.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Alipour A, Shohaee S, Mohebali M, Tehranidoost M, Masoleh FA, Keshavarz H (2011) Toxoplasma infection in schizophrenia patients: a comparative study with control group. Iran J Parasitol 6:31–37
Alvarado-Esquivel C, Alanis-Quinones OP, Arreola-Valenzuela MÁ, Rodriguez-Briones A, Piedra-Nevarez LJ, Duran-Morales E, Estrada-Martinez S, Martinez-Garcia SA, Liesenfeld O (2006) Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis 6:1–7
Alvardo-Esquivel C, Urbina-Álvarez JD, Estrada-Martinez S, Torres-Castorena A, Molotla-De-Leon G, Liesenfeld O, Dubey JP (2011) Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population. Parasitol Int 60:151–155. doi:10.1016/j.parint.2010.12.003
Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerma SA, Balis T, Cabassa JA, Scrandis DA, Tonelli LH (2009) Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 3:905–908. doi:10.1097/NMD.0b013e3181c29a23
Barragan A, Sibley LD (2002) Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J Exp Med 195:1625–1633
Çelik T, Kamisli Ö, Babur C, Çevlik MÖ, Öztuna D, Altinayar S (2010) Is there a relationship between Toxoplasma gondii infection and idiopathic Parkinson’s disease? Scand J Infect Dis 42:604–608. doi:10.3109/00365541003716500
Cetinkaya Z, Yazar S, Gecici O, Namli MN (2007) Anti-Toxoplasma gondii antibodies in patients with schizophrenia—preliminary findings in a Turkish sample. Schizophr Bull 33:789–791. doi:10.1093/schbul/sbm021
Chen H, Zhang S, Schwarzschild MA, Hernan M, Logroscino G, Willett W, Ascherio A (2004) Folate intake and risk of Parkinson’s disease. Am J Epidemiol 160:368–375
Daryani A, Sharif M, Hosseni SH, Karimi S, Gholami S (2010) Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City Iran. Trop Biomed 27:476–482
De lau LM, Breteler M (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535
Dubey J (2004) Toxoplasmosis—a waterborne zoonosis. Vet Parasitol 126:57–72
Ferreira MS, Borges AS (2002) Some aspects of protozoan infections in immunocompromised patients: a review. Mem Inst Oswaldo Cruz 97:443–457
Fleger J (2007) Effects of Toxoplasma on human behavior. Schizophr Bull 33:757–776. doi:10.1093/schbul/sb1074
Gaskell EA, Smith JE, Pinney JW, Westhead DR, Mcconkey GA (2009) A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS One 4:e4801. doi:10.1371/journal.pone.0004801
Gazewood JD, Richards DR, Clebak K (2013) Parkinson disease: an update. Am Fam Physician 87:267–273
Guttmacher AE, Collins FS, Nussbaum RL, Ellis CE (2003) Alzheimer’s disease and Parkinson’s disease. N Eng J Med 348:1356–1364. doi:10.1056/NEJM2003RA020003
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184. doi:10.1136/jnnp.55.3181
Jung BK, Pyo KH, Shin KY, Hwang Y, Lim H, Lee SJ, Moon JH, Lee SH, Suh YH, Chai JY (2012) Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer’s disease. PLoS One 7:e33312. doi:10.1371/journal.pone.0033312
Koseoglu E, Yazar S, Koc I (2009) Is Toxoplasma gondii a causal agent in migraine? Am J Med Sci 338:120–122. doi:10.1097/MAJ.0b013e31819fBcac
Kusbce OY, Miman O, Yaman M, Aktepe OC, Yazar S (2011) Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord 25:1–3. doi:10.1097/WAD.0b013e3181f73bc2
Ling VJ, Lester D, Mortensen PB, Langenberg PW, Postolache TT (2011) Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 199:440–444. doi:10.1097/NMD.0b013e318221416e
Logroscino G (2005) The role of early life environmental risk factors in Parkinson disease: what is the evidence? Environ Health Perspect 113:1234–1238
Miman O, Kusbeci OY, Aktepe OC, Cetinkaya Z (2010a) The probable relation between Toxoplasma gondii and Parkinson’s disease. Neurosci Lett 475:129–131
Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S (2010b) Is there any role of Toxoplasma gondii in the etiology of obsessive–compulsive disorder? Psychiatry Res 177:263–265. doi:10.1016/i.psychres.2009.12.013
Mostavafi S, JalaliMonfarad L (2012) Toxoplasmosis epidemiology in Iran: a systematic review. J Isfahan Med Sch 30:1–15
Newman EJ, Breen K, Patterson J, Hadley DM, Grosset KA, Grosset DG (2009) Accuracy of Parkinson’s disease diagnosis in 610 general practice patients in the West of Scotland. Mov Disord 24:2379–2385. doi:10.1002/mds.22829
Nuti A, Ceravolo R, Dell’agnello G, Gambaccini G, Bellini G, Kiferle L, Rossi C, Logi C, Bonuccelli U (2004) Environmental factors and Parkinson’s disease: a case–control study in the Tuscany region of Italy. Parkinsonism Relat Disord 10:481–485
Obeso JA, Marin C, Rodriguez-Oroz C, Blesa J, Benitez-Temino B, Mena-Segovia J, Rodriguez M, Olanow CW (2008) The basal ganglia in Parkinson’s disease: current concepts and unexplained observations. Ann Neurol 64:S30–S46. doi:10.1002/ana.21481
Okusaga O, Langenberg P, Sleemi A, Vaswani D, Giegling I, Hartmaan AM, Konte B, Friedl M, Groer MW, Yolken RH (2011) Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res 133:150–155. doi:10.1016/i.schres.2011.08.006
Olanow CW, Stern MB, Sethi K (2009) The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 72:S1–S136
Pandey S (2012) Parkinson’s disease: recent advances. J Assoc Physicians India 60:30–32
Pearce BD, Kruszon-Moran D, Jones JL (2012) The relationship between Toxoplasma gondii infection and mood disorders in the third national health and nutrition survey. Biol Psychiatry 72:290–295. doi:10.1016/i.biopsych.2012.01.003
Priyadarshi A, Khuder SA, Schaub EA, Preyadarshi SS (2001) Environmental risk factors and Parkinson’s disease: a meta-analysis. Environ Res 86:122–127
Robert-Gangneux F, Darde ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25:264–296. doi:10.1128/CMR.0501.311
Skallova A, Kodym P, Frynta D, Flege J (2006) The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitol 133:525–535. doi:10.1017/S0031182006000886
Torrey EF, Bartko JJ, Lun ZR, Yolken RH (2007) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 33:729–736. doi:10.1093/schbul/sbl050
Vlajinac H, Dzoljic E, Maksimovlic J, Marinkovic J, Sipetic S, Kostic V (2013) Infections as a risk factor for Parkinson’s disease: a case-control study. Int J Neurosci 123:329–332
Yagmur F, Yazar S, Temel HO, Cavusoglu M (2010) May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects? Forensic Sci Int 199:15–17
Yazar S, Yaman O, Eser B, Altuntas F, Kurnaz F, Şahin I (2004) Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia. J Med Microbiol 53:1183–1186. doi:10.1099/jmm.045587-0
Yolken R, Dickerson F, Fuller Torrey E (2009) Toxoplasma and schizophrenia. Parasite Immunol 31:706–715. doi:10.1111/j.1365-3024.2009.01131.x
Zhu S, Du Y, Li Q, Dong Z (2007) High risk of psychosis may be associated with toxoplasmosis. Life Sci J 4:38–41
Acknowledgments
This work was supported fully by Neurosciences Research Center (Grant no: 1303), Tabriz University of Medical Sciences, Tabriz, Iran. This is a report of a database from thesis of Faezeh Hamidi registered in Tabriz University of Medical Sciences.
Conflict of interest
The authors have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Mahami Oskouei, M., Hamidi, F., Talebi, M. et al. The correlation between Toxoplasma gondii infection and Parkinson’s disease: a case-control study. J Parasit Dis 40, 872–876 (2016). https://doi.org/10.1007/s12639-014-0595-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12639-014-0595-3


